Answers are grounded in this paper and cite their sources.
Rationale: Spinal cord injury (SCI) results in neural tissue damage. However, the limited regenerative capacity of adult mammals' axons upon SCI leads to persistent neurological dysfunction. Thus, exploring the pathways that can enhance axon regeneration in injured spinal cord is of great significance. Methods: Through the utilization of single-cell RNA sequencing in this research, a distinct subpopulation of bone marrow mesenchymal stem cells (BMSCs) that exhibits the capacity to facilitate axon regeneration has been discovered. Subsequently, the CD271 + CD56 + BMSCs subpopulation was isolated using flow cytometry, and the exosomes derived from this subpopulation (CD271 + CD56 + BMSC-Exos) were extracted and incorporated into a hydrogel to create a sustained release system. The aim was to investigate the therapeutic effects of CD271 + CD56 + BMSC-Exos and elucidate the underlying mechanisms involved in promoting axon regeneration and neural function recovery.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: